Kyowa Hakko Kirin Co., Ltd.


  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
Sep 22, 2017
Prev close: 1,877
Sep 22, 2017
Market cap:
Market cap(USD):
Shares: 576.48M

Currency in JPY

Company profile

Market(Ticker): TKS(4151)
Health Technology
Pharmaceuticals: Other
Full time employees: 7,465

Business summary

Kyowa Hakko Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

In the news

Financial highlights

Dec 2016

  • Local currency
  • US Dollar
Revenue 343,019M
Gross profit 186,082M
Operating income 31,639M
Income before tax 30,288M
Net income 18,669M
EBITDA 67,310M
Diluted EPS 34.08
Dividends per share 25
Total assets 697,167M
Total liabilities 96,419M
Total equity 600,745M
Operating cash flow 65,752M

Currency in JPY

Revenue 3,156.84M
Gross profit 1,712.53M
Operating income 291.17M
Income before tax 278.74M
Net income 171.81M
EBITDA 619.46M
Diluted EPS 0.31
Dividends per share 0.23
Total assets 5,977.33M
Total liabilities 826.67M
Total equity 5,150.64M
Operating cash flow 605.12M

Currency in USD

Valuation measures

Dec 2016

PER 47.36
ROA 2.63%
ROE 3.07%
Operating margin 9.22%
Profit margin 5.44%

Key executive

  • President & Representative Director: Nobuo Hanai
  • Director, Managing Executive Officer, GM-R&D: Yoichi Sato
  • Representative Director & Executive Vice President: Hiroyuki Kawai
  • Executive Officer & GM-Quality Assurance: Kazuyoshi Adachi
  • Executive Officer & Manager-Corporate Planning: Wataru Murata

Share holders

  • Kirin Holdings Co., Ltd.(50.1%)
  • Kyowa Hakko Kirin Co., Ltd.(5.0%)
  • Nomura Asset Management Co., Ltd.(3.1%)
  • Japan Agricultural Cooperatives Group(1.8%)
  • Nikko Asset Management Co., Ltd.(1.2%)
  • Mizuho Bank Pension Fund(1.1%)
  • Wellington Management Co. LLP(1.1%)
  • Daiwa Asset Management Co. Ltd.(1.0%)
  • The Vanguard Group, Inc.(0.9%)
  • Norges Bank Investment Management(0.7%)


  • Website:
  • Address: Otemachi Financial City Grand Cube, 1-9-2 Otemachi, Tokyo, 100-0004, Japan
  • Phone: +81.3.5205.7200

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.